Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.

Article Details

Citation

Boehm MF, McClurg MR, Pathirana C, Mangelsdorf D, White SK, Hebert J, Winn D, Goldman ME, Heyman RA

Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.

J Med Chem. 1994 Feb 4;37(3):408-14.

PubMed ID
8308867 [ View in PubMed
]
Abstract

all-trans-Retinoic acid is known to bind to the retinoic acid receptors (RARs) resulting in an increase in their transcriptional activity. In contrast, recently identified 9-cis-retinoic acid (9-cis-RA), which is an additional endogenous RA isomer, is capable of binding to both RARs and retinoid X receptors (RXRs). These distinct properties have raised questions as to the biological role governed by these two retinoic acid isomers and the set of target genes that they regulate. Herein, we report the synthesis of high specific activity [3H]-9-cis-RA and its application to study the ligand-binding properties of the various retinoid receptor subtypes. We examined the binding properties of RARs and RXRs for a series of synthetic retinoids and compared the ligand-binding properties of these arotinoid analogs with their ability to regulate gene expression via the retinoid receptors in a cotransfection assay. The utilization of the [3H]-9-cis-RA competitive binding assay and the cotransfection assay has made it possible to rapidly identify important structural features of retinoids leading to increased selectivity for either the RAR or RXR receptor subtypes.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
Arotinoid acidRetinoic acid receptor betaEC 50 (nM)3N/AN/ADetails
Arotinoid acidRetinoic acid receptor betaIC 50 (nM)5N/AN/ADetails
TretinoinRetinoic acid receptor alphaEC 50 (nM)350N/AN/ADetails
TretinoinRetinoic acid receptor alphaIC 50 (nM)15N/AN/ADetails
TretinoinRetinoic acid receptor alphaEC 50 (nM)191N/AN/ADetails
TretinoinRetinoic acid receptor alphaIC 50 (nM)7N/AN/ADetails
TretinoinRetinoic acid receptor betaIC 50 (nM)13N/AN/ADetails
TretinoinRetinoic acid receptor betaIC 50 (nM)7N/AN/ADetails
TretinoinRetinoic acid receptor betaEC 50 (nM)80N/AN/ADetails
TretinoinRetinoic acid receptor betaEC 50 (nM)50N/AN/ADetails
TretinoinRetinoic acid receptor gammaIC 50 (nM)17N/AN/ADetails
TretinoinRetinoic acid receptor gammaEC 50 (nM)10N/AN/ADetails
TretinoinRetinoic acid receptor gammaIC 50 (nM)18N/AN/ADetails
TretinoinRetinoic acid receptor gammaEC 50 (nM)45N/AN/ADetails
TretinoinRetinoic acid receptor RXR-alphaEC 50 (nM)900N/AN/ADetails
TretinoinRetinoic acid receptor RXR-alphaIC 50 (nM)>1000N/AN/ADetails
TretinoinRetinoic acid receptor RXR-alphaEC 50 (nM)100N/AN/ADetails
TretinoinRetinoic acid receptor RXR-alphaIC 50 (nM)32N/AN/ADetails
TretinoinRetinoic acid receptor RXR-betaEC 50 (nM)1400N/AN/ADetails
TretinoinRetinoic acid receptor RXR-betaIC 50 (nM)12N/AN/ADetails
TretinoinRetinoic acid receptor RXR-betaIC 50 (nM)>1000N/AN/ADetails
TretinoinRetinoic acid receptor RXR-betaEC 50 (nM)200N/AN/ADetails
TretinoinRetinoic acid receptor RXR-gammaEC 50 (nM)140N/AN/ADetails
TretinoinRetinoic acid receptor RXR-gammaIC 50 (nM)4N/AN/ADetails
TretinoinRetinoic acid receptor RXR-gammaEC 50 (nM)1100N/AN/ADetails
TretinoinRetinoic acid receptor RXR-gammaIC 50 (nM)350N/AN/ADetails